GlassScriptPhysician profile
Daniel S De Feo
NPI 1912147166
$1,755.20
in general payments reported to CMS, 2019-2025
17 companies · $567 in 2025
The $567 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $240 · 2021: $12.24 · 2022: $125 · 2023: $15.13 · 2024: $437 · 2025: $567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,020.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,019.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $285.31 | 2024-2025 | Xyosted |
| Phathom Pharmaceuticals, INC. | $179.71 | 2025 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $146.00 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $143.26 | 2024-2025 | Strensiq |
| Novo Nordisk INC | $124.73 | 2022 | |
| Mannkind Corporation | $123.44 | 2019 | |
| Amarin Pharma, INC. | $122.96 | 2019 | |
| Boston Scientific Corporation | $122.58 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $120.29 | 2024 | Airsupra |
| Insmed, INC. | $117.00 | 2020 | |
| Janssen Pharmaceuticals, INC | $112.51 | 2019 | |
| Paratek Pharmaceuticals, INC. | $51.93 | 2024-2025 | Nuzyra, Xhance |
| Lilly USA, LLC | $35.97 | 2025 | Zepbound, Mounjaro |
| Exact Sciences Corporation | $24.81 | 2025 | Cologuard Collection Kit |
| Abbvie INC. | $17.33 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.13 | 2023 | |
| Sanofi-Aventis U.S. LLC | $12.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel De Feo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.